Ortho Biotech Products, LP, a Johnson & Johnson Company, markets PROCRIT® (Epoetin alfa). PROCRIT® is for anemic chemotherapy patients with most types of cancer.
Click on the image below to go to the web site maintained by
The Abramson Cancer Center of the University of Pennsylvania
is not responsible for that site's content.